Celanese Corporation · NYSE:CE

Celanese — Q3 2026 Earnings Presentation

13 slides from Celanese's earnings presentation, Nov 2, 2026

  1. Slide 1: Investor Presentation Q3 2026

    Investor Presentation Q3 2026 November 2026

  2. Slide 2: Disclosures: Forward-Looking Statements

    Celanese Corporation Disclosures Forward-Looking Statements This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation’s (the “Company”) plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capit

  3. Slide 3: Discussion Topics

    Discussion Topics 3 Earnings update Key actions and near- term imperatives

  4. Slide 4: Q3 2026 results and highlights

    Q3 2026 results and highlights Q3 2026 Results 4 Q3 2026 Highlights * Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-US GAAP Financi

  5. Slide 5: 2026 outlook

    ▪ Raising FY2026 FCF* range to $750 to $800 million ▪ Continued focus in EM on growth platforms, while capturing price to mitigate higher input costs ▪ Drive AC business model to maximize margin opportunity in Western Hemisphere as supply- related opportunities normalize ▪ Western Hemisphere seasona

  6. Slide 6: Continued execution of actions drives sustained value creation in 2026 and beyond

    Continued execution of actions drives sustained value creation in 2026 and beyond 6 ✓ Actions enable increased free cash flow* target to $750 – $800 million in 2026 ✓ Reduced total debt by fully repaying 2026 maturities ✓ Advancing steps towards closing announced sale of additional 19% of Nutrinova

  7. Slide 7: Functional Cost and Net Interest Expense Reductions

    Functional Cost and Net Interest Expense1 Reductions Cumulative actions in 2026-2027 expected to support ~$175 M in cost reductions 7 Engineered Materials Grow & Fortify Cost Programs Acetyl Chain Footprint Optimization and Productivity Lower functional costs, including SG&A reductions + decreases i

  8. Slide 8: EM's breadth of offering into high-value applications is driving mix improvement

    EM’s breadth of offering into high-value applications is driving mix improvement and earnings growth 8 *Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, pleas

  9. Slide 9: Evolution to Western Hemisphere and downstream focus drives AC earnings power

    69% 70% 61% 68% 68% 70% 73% 73% 2 0 1 9 2 0 2 0 2 0 2 1 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 3 Q '2 6 Evolution to Western Hemisphere and downstream focus drives AC earnings power and future growth opportunity 9 Strength in downstream Western Hemisphere positions AC to outperform when building and constr

  10. Slide 10: Raising full-year 2026 free cash flow guidance to $750 - $800 million

    Raising full-year 2026 free cash flow* guidance to $750 - $800 million 10* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-US GAAP Fi

  11. Slide 11: Strong and sustainable free cash flow generation and divestitures drive deleveraging

    0 200 400 600 800 1000 2025 2026 2027 0 500 1000 1500 2025 2026 2027 1 2 3 1 2 3 Strong and sustainable free cash flow* generation and divestitures drive deleveraging Free Cash Flow* and Divestitures ($M) 11 Sustainable cash generation capabilities accelerate debt paydown Cash flow capabilities and

  12. Slide 12: 2027 maturities well-funded; building towards 2028

    Undrawn Revolver 2027 maturities well-funded; building towards 2028 with baseline cash generation and targeted divestitures 12 Differentiated cash generation capabilities and liquidity drive deleveraging and enhance future flexibility * Represents a non-GAAP measure. For information on historical no

  13. Slide 13: Celanese Offers a Compelling Investment Opportunity

    Growth pathways that target attractive, scalable end markets Actions underway to deliver near-term earnings improvement Strong earnings leverage as demand recovers Laser focused on deleveraging History of innovation as customer solutions provider Attractive valuation with upside potential for stock

Celanese — Q3 2026 Earnings Presentation on 6ix